Latest Biologic Stories
ALEXANDRIA, Va., Feb.
SHANGHAI, Feb. 27, 2015 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc.
SAN DIEGO, Feb. 27, 2015 /PRNewswire/ -- Pfenex Inc.
Dermatology offices, psoriasis patients encouraged to join the research efforts PORTLAND, Ore., Feb.
Product is the first approved monoclonal antibody to aid in the treatment of canine B-cell lymphoma KANSAS CITY, Kan., Feb. 24, 2015 /PRNewswire/ -- Aratana Therapeutics, Inc.
New research finds only biosimilars for blockbuster biologics are likely viable ST. PAUL, Minn., Feb.
DUBLIN, Feb .20, 2015 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/4rqtv7/global)
-- Hungarian National Registry reports interim results following Inflectra therapy in 90 patients with Crohn's disease and ulcerative colitis BARCELONA and MADRID, Spain, Feb.
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that Dr.
Company currently has two biosimilar applications (filgrastim [Neupogen(®)]) and pegfilgrastim [Neulasta(®)]) under active review by FDA. TORONTO, Feb.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.